BioWin
@BioWin_asbl
Followers
2K
Following
1K
Media
691
Statuses
3K
Accelerating Belgian health-tech & biopharma innovation
Wallonia (Belgium)
Joined June 2009
Full-Life Technologies announces US$77 million financing to accelerate the development of its radiopharmaceutical pipeline worldwide and manufacturing capabilities in Belgium. https://t.co/X8I2cbybW9
0
0
2
KiOmed Pharma’s innovative osteoarthritis solution, KioMedine-vs-one, has officially been approved by the Chinese FDA, bringing treatment to 100 million patients. https://t.co/9nSVz6mNdV
0
0
0
BiOkuris Announces Positive Results from Pivotal IBS Study (Vitabiotic) Evaluating BK002 Synbiotic formulation demonstrates dual therapeutic effect on gastrointestinal symptoms and anxiousness.
lecho.be
Belle avancée pour BiOkuris, la spin-off de la biotech KitoZyme. Un essai clinique vient de démontrer que son dernier produit de nutrition médicale permet de réduire les symptômes des patients...
1
0
0
Hyloris Pharmaceuticals announces positive clinical study results for atomoxetine oral solution. https://t.co/yjCv9WM1iS
0
0
0
Hyloris Partners with Kuvatris Therapeutics to Advance Suramin IV Development for Sleeping Sickness, Targeting a Priority Review Voucher. https://t.co/pk36yA9Bwx
0
2
0
Novadip Biosciences received RMAT designation for NVD003, its regenerative treatment for congenital pseudarthosis of the tibia. https://t.co/04ncZrOi8l
0
0
0
UCB announces major U.S. investment to expand biologics manufacturing capacity. @ucb_news
0
0
1
ATB Therapeutics Announces Appointment of Dr. Torsten Dreier as Chief Development Officer and Opening of New R&D Hub in Gent. https://t.co/lLeMFwh6WK
0
0
0
For the first time in Belgium, two patients suffering from sarcomas, rare cancers that affect bone or soft tissue, have undergone surgery using augmented reality.
1
0
1
Rystiggo (rozanolixizumab) receives approval in Japan for two new administration methods as UCB begins ONWARD program for patient support. https://t.co/1QeoBq6GjB
0
0
0
Do you have an innovative idea in health and need the right partners to bring it to life? If your project fits within one of BioWin’s strategic themes - #biopharma or #healthtech - then you may be eligible for funding. https://t.co/Eq0PnRuTXp
0
0
0
One more step for AbolerIS Pharma! The biotech has just dosed the first participants in a Phase 1 trial for ABO21009, a first-in-class anti-CD45RC monoclonal antibody for rheumatoid arthritis. https://t.co/MzHR0iYfTY
1
0
0
Aptissen and kiOmed Pharma forge a strategic alliance bringing breakthrough in Osteoarthritis Treatment.
biowin.org
0
0
0
KiOmed Pharma is continuing to grow, having raised €18 million to support the commercial expansion of its osteoarthritis gel and to move forward with new developments in dermatology and ophthalmology. https://t.co/SGGllQoU5x
0
0
0
White Raven, a newly established CDMO, obtains GMP certification for its aseptic fill & finish facility with a robotic gloveless workcell for small-batch manufacturing. https://t.co/Kg8qs7BsCu
0
0
0
Synergia Medical announces strong results for NAO.VNS™ first-in-human study. https://t.co/ghM9lbcnw7
0
0
0
4Tissue secures an additional €1.5M in funding and appoints Dr. Katleen Verleysen as independent chair of the board. https://t.co/TFmbk4oJfk
0
0
0